AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇦
Neostigmine Methylsulphate in South Africa
3 products registered with SAHPRA — 3 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| NEOSTIGMINE METHYLSULPHATE 2,5 mg/1 ml (AMPOULES) FRESENIUS | W/5.3/260 | Fresenius Kabi Manufacturing SA (Pty) Ltd | active | 1 Jan 1900 |
| PHARMA-Q NEOSTIGMINE INJECTION 2,5 mg/ml (5 ml A/V) | 31/5.3/0394 | Pharma-Q Holdings (Pty) Ltd | active | 1 Jan 1900 |
| PHARMA-Q NEOSTIGMINE INJECTION 2,5 mg/1 ml A/A | 31/5.3/0393 | Pharma-Q Holdings (Pty) Ltd | active | 1 Jan 1900 |
Neostigmine Methylsulphate — SAHPRA Registration Details
SAHPRA (South Africa) has 3 registered products containing Neostigmine Methylsulphate, of which 3 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.
Track Neostigmine Methylsulphate registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.